Skip to main navigation Skip to search Skip to main content

Exploring the effects of cigarette smoking on inflammatory bowel disease using Mendelian randomisation

Research output: Contribution to journalArticle (Academic Journal)peer-review

13 Citations (Scopus)
150 Downloads (Pure)

Abstract

Background. Previous observational evidence has suggested an association between smoking and inflammatory bowel disease (IBD).

Methods. We used observational techniques followed by Mendelian randomisation (MR) to explore if smoking is a causal factor in the development of IBD and its subtypes.

Results. In those who have ever smoked, we observed increased risk of IBD, and, in current smokers, we observed increased risk of Crohn’s disease and decreased risk of Ulcerative Colitis. However, our MR analyses found little evidence that smoking affects the development of IBD.

Conclusion. Overall, our results suggest that smoking does not causally influence the risk of IBD.
Original languageEnglish
Number of pages7
JournalCrohn's and Colitis 360
Volume2
Issue number1
DOIs
Publication statusPublished - 12 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Groups and Themes

  • Physical and Mental Health
  • Tobacco and Alcohol
  • TARG

Keywords

  • smoking
  • inflammatory bowel disease
  • Mendelian randomisation
  • UK Biobank

Fingerprint

Dive into the research topics of 'Exploring the effects of cigarette smoking on inflammatory bowel disease using Mendelian randomisation'. Together they form a unique fingerprint.

Cite this